LMT (N = 7) | HMT (N = 11) | ||||||
---|---|---|---|---|---|---|---|
HE (n = 2) | ES-H (n = 1) | EHE (n = 4) | Pa (%) | AS (n = 9) | EA (n = 2) | Pa (%) | |
Multifocality | 0 | 0 | 4 | 57.1 | 1 | 0 | 9.1 |
Expansion | 0 | 1 | 2 | 42.9 | 5 | 1 | 54.5 |
Residual bone | 1 | 0 | 3 | 57.1 | 3 | 0 | 27.3 |
Peripheral sclerosis | 1 | 1 | 4 | 85.7 | 6 | 2 | 72.7 |
Cortical destruction | 1 | 1 | 4 | 85.7 | 8 | 1 | 81.8 |
Periosteal reaction | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pathologic fracture | 1 | 0 | 0 | 14.3 | 2 | 1 | 27.3 |
Cystic/necrotic component | NAb | 1 | 2 | 42.9 | 7 | 2 | 81.8 |
Hemorrhage | NAb | 0 | 0 | 0 | 2 | 1 | 27.3 |
Ill-defined margin | 1 | 0 | 1 | 28.6 | 5 | 1 | 54.5 |
Enhancement | |||||||
Homogeneous | 0 | 0 | 0 | 0 | 1 | 0 | 9.1 |
Slightly heterogeneous | 1 | 0 | 4 | 71.4 | 1 | 0 | 9.1 |
Obviously heterogeneous | 0 | 1 | 0 | 14.3 | 7 | 2 | 81.8 |